| Literature DB >> 28501088 |
Radka Obermannová1, Florian Lordick2.
Abstract
Metastatic gastric cancer is an incurable disease. Systemic chemotherapy prolongs survival, improves symptom control, and helps maintain a better quality of life of patients with metastatic gastric cancer. HER2 testing of the primary tumor and/or the metastases is warranted before initiation of first-line treatment. This review article outlines the indication and clinical data of medical treatment of advanced gastric cancer and highlights aspects of quality of life.Entities:
Keywords: Chemotherapy; Doublet; Gastric cancer; Metastases; Radiotherapy; Sequence; Surgery; Triplet
Mesh：
Substances：
Year: 2017 PMID： 28501088 DOI： 10.1016/j.hoc.2017.01.006
Source DB: PubMed Journal: Hematol Oncol Clin North Am ISSN： 0889-8588 Impact factor: 3.722